XML 59 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Information Provided in Connection with Investments in Deferred Annuity Contracts and SignatureNotes Issued or Assumed by John Hancock Life Insurance Company (U.S.A.)
12 Months Ended
Dec. 31, 2022
Text block [abstract]  
Information Provided in Connection with Investments in Deferred Annuity Contracts and SignatureNotes Issued or Assumed by John Hancock Life Insurance Company (U.S.A.)
Note 24    Information Provided in Connection with Investments in Deferred Annuity Contracts and
Signature
Notes Issued or Assumed by John Hancock Life Insurance Company (U.S.A.)
The following condensed consolidated financial information, presented in accordance with IFRS, and the related disclosure have been included in these Consolidated Financial Statements with respect to JHUSA in compliance with Regulation
S-X
and Rule
12h-5
of the United States Securities and Exchange Commission (the “Commission”). These financial statements are incorporated by reference in certain of the MFC and its subsidiaries registration statements that are described below and relate to MFC’s guarantee of certain securities to be issued by its subsidiaries.
JHUSA maintains a book of deferred annuity contracts that feature a market value adjustment, some of which are registered with the Commission. The deferred annuity contracts may contain variable investment options along with fixed investment period options, or may offer only fixed investment period options. The fixed investment period options enable the participant to invest fixed amounts of money for fixed terms at fixed interest rates, subject to a market value adjustment if the participant desires to terminate a fixed investment period before its maturity date. The annuity contract provides for the market value adjustment to keep the parties whole with respect to the fixed interest bargain for the entire fixed investment period. These fixed investment period options that contain a market value adjustment feature are referred to as “MVAs”.
JHUSA has sold medium-term notes to retail investors under its
Signature
Notes program.
Effective December 31, 2009, John Hancock Variable Life Insurance Company (the “Variable Company”) and John Hancock Life Insurance Company (the “Life Company”) merged with and into JHUSA. In connection with the mergers, JHUSA assumed the Variable Company’s rights and obligations with respect to the MVAs issued by the Variable Company and the Life Company’s rights and obligations with respect to the
Signature
Notes issued by the Life Company.
MFC fully and unconditionally guaranteed the payment of JHUSA’s obligations under the MVAs and under the
Signature
Notes (including the MVAs and
Signature
Notes assumed by JHUSA in the merger), and such MVAs and the
Signature
Notes were registered with the Commission. The
Signature
Notes and MVAs assumed or issued by JHUSA are collectively referred to in this note as the “Guaranteed Securities”. JHUSA is, and each of the Variable Company and the Life Company was, a wholly owned subsidiary of MFC.
MFC’s guarantees of the Guaranteed Securities are unsecured obligations of MFC and are subordinated in right of payment to the prior payment in full of all other obligations of MFC, except for other guarantees or obligations of MFC which by their terms are designated as ranking equally in right of payment with or subordinate to MFC’s guarantees of the Guaranteed Securities.
The laws of the State of New York govern MFC’s guarantees of the
Signature
Notes issued or assumed by JHUSA and the laws of the Commonwealth of Massachusetts govern MFC’s guarantees of the MVAs issued or assumed by JHUSA. MFC has consented to the jurisdiction of the courts of New York and Massachusetts. However, because a substantial portion of MFC’s assets are located outside the United States, the assets of MFC located in the United States may not be sufficient to satisfy a judgment given by a federal or state court in the United States to enforce the subordinate guarantees. In general, the federal laws of Canada and the laws of the Province of Ontario, where MFC’s principal executive offices are located, permit an action to be brought in Ontario to enforce such a judgment provided that such judgment is subsisting and unsatisfied for a fixed sum of money and not void or voidable in the United States and a Canadian court will render a judgment against MFC in a certain dollar amount, expressed in Canadian dollars, subject to customary qualifications regarding fraud, violations of public policy, laws limiting the enforcement of creditor’s rights and applicable statutes of limitations on judgments. There is currently no public policy in effect in the Province of Ontario that would support avoiding the recognition and enforcement in Ontario of a judgment of a New York or Massachusetts court on MFC’s guarantees of the
Signature
Notes issued or assumed by JHUSA or a Massachusetts court on guarantees of the MVAs issued or assumed by JHUSA.
MFC is a holding company. MFC’s assets primarily consist of investments in its subsidiaries. MFC’s cash flows primarily consist of dividends and interest payments from its operating subsidiaries, offset by expenses and shareholder dividends and MFC stock repurchases. As a holding company, MFC’s ability to meet its cash requirements, including, but not limited to, paying any amounts due under its guarantees, substantially depends upon dividends from its operating subsidiaries.
These subsidiaries are subject to certain regulatory restrictions under laws in Canada, the United States and certain other countries, which may limit their ability to pay dividends or make contributions or loans to MFC. For example, some of MFC’s subsidiaries are subject to restrictions prescribed by the ICA on their ability to declare and pay dividends. The restrictions related to dividends imposed by the ICA are described in note 13.
 
In the United States, insurance laws in Michigan, New York, and Massachusetts, the jurisdictions in which certain of MFC’s U.S. insurance company subsidiaries are domiciled, impose general limitations on the payment of dividends and other upstream distributions or loans by these insurance subsidiaries. These limitations are described in note 13.
In Asia, the insurance laws of the jurisdictions in which MFC operates either provide for specific restrictions on the payment of dividends or other distributions or loans by subsidiaries or impose solvency or other financial tests, which could affect the ability of subsidiaries to pay dividends in certain circumstances.
There can be no assurance that any current or future regulatory restrictions in Canada, the United States or Asia will not impair MFC’s ability to meet its cash requirements, including, but not limited to, paying any amounts due under its guarantees.
The following condensed consolidated financial information, presented in accordance with IFRS, reflects the effects of the mergers and is provided in compliance with Regulation
S-X
and in accordance with Rule
12h-5
of the Commission.
Condensed Consolidated Statement of Financial Position
 
As at December 31, 2022
  MFC
(Guarantor)
    JHUSA
(Issuer)
    Other
subsidiaries
    Consolidation
adjustments
    Consolidated
MFC
 
Assets
                                       
Invested assets
 
$
63
 
 
$
116,463
 
 
$
297,996
 
 
$
(521
 
$
414,001
 
Investments in unconsolidated subsidiaries
 
 
67,209
 
 
 
8,819
 
 
 
22,053
 
 
 
(98,081
 
 
 
Reinsurance assets
 
 
 
 
 
61,511
 
 
 
12,137
 
 
 
(25,936
 
 
47,712
 
Other assets
 
 
334
 
 
 
9,456
 
 
 
48,135
 
 
 
(19,259
 
 
38,666
 
Segregated funds net assets
 
 
 
 
 
173,417
 
 
 
177,361
 
 
 
(2,216
 
 
348,562
 
Total assets
 
$
67,606
 
 
$
369,666
 
 
$
557,682
 
 
$
(146,013
 
$
848,941
 
Liabilities and equity
                                       
Insurance contract liabilities
 
$
 
 
$
156,205
 
 
$
241,830
 
 
$
(26,630
 
$
371,405
 
Investment contract liabilities
 
 
 
 
 
1,418
 
 
 
1,830
 
 
 
 
 
 
3,248
 
Other liabilities
 
 
451
 
 
 
20,159
 
 
 
55,304
 
 
 
(18,923
 
 
56,991
 
Long-term debt
 
 
6,234
 
 
 
 
 
 
 
 
 
 
 
 
6,234
 
Capital instruments
 
 
4,860
 
 
 
614
 
 
 
648
 
 
 
 
 
 
6,122
 
Segregated funds net liabilities
 
 
 
 
 
173,417
 
 
 
177,361
 
 
 
(2,216
 
 
348,562
 
Shareholders’ and other equity holders’ equity
 
 
56,061
 
 
 
17,853
 
 
 
80,391
 
 
 
(98,244
 
 
56,061
 
Participating policyholders’ equity
 
 
 
 
 
 
 
 
(1,346
 
 
 
 
 
(1,346
Non-controlling
interests
 
 
 
 
 
 
 
 
1,664
 
 
 
 
 
 
1,664
 
Total liabilities and equity
 
$
67,606
 
 
$
369,666
 
 
$
557,682
 
 
$
(146,013
)
 
$
  848,941
 
Condensed Consolidated Statement of Financial Position
 
As at December 31, 2021   MFC
(Guarantor)
    JHUSA
(Issuer)
    Other
subsidiaries
    Consolidation
adjustments
    Consolidated
MFC
 
Assets
                                       
Invested assets
  $ 78     $ 116,705     $ 310,679     $ (364   $ 427,098  
Investments in unconsolidated subsidiaries
    68,655       9,107       20,788       (98,550      
Reinsurance assets
          63,838       11,309       (30,568     44,579  
Other assets
    211       18,085       49,956       (22,074     46,178  
Segregated funds net assets
          204,493       197,220       (1,925     399,788  
Total assets
  $ 68,944     $ 412,228     $ 589,952     $ (153,481   $ 917,643  
Liabilities and equity
                                       
Insurance contract liabilities
  $     $ 166,535     $ 257,044     $ (31,304   $ 392,275  
Investment contract liabilities
          1,227       1,890             3,117  
Other liabilities
    899       21,806       50,836       (21,809     51,732  
Long-term debt
    4,882                         4,882  
Capital instruments
    4,755       579       1,646             6,980  
Segregated funds net liabilities
          204,493       197,220       (1,925     399,788  
Shareholders’ and other equity holders’ equity
    58,408       17,588       80,855       (98,443     58,408  
Participating policyholders’ equity
                (1,233           (1,233
Non-controlling
interests
                1,694             1,694  
Total liabilities and equity
  $   68,944     $   412,228     $   589,952     $   (153,481   $   917,643  
 
Condensed Consolidated Statement of Income
 
For the year ended December 31, 2022
  MFC
(Guarantor)
    JHUSA
(Issuer)
    Other
subsidiaries
    Consolidation
adjustments
    Consolidated
MFC
 
Revenue
                                       
Gross premiums
 
$
 
 
$
7,924
 
 
$
37,041
 
 
$
(863
 
$
44,102
 
Premiums ceded to reinsurers
 
 
 
 
 
(2,561
 
 
(4,662
 
 
974
 
 
 
(6,249
Net premium income
 
 
 
 
 
5,363
 
 
 
32,379
 
 
 
111
 
 
 
37,853
 
Net investment income (loss)
 
 
554
 
 
 
(9,714
 
 
(19,446
 
 
(1,264
 
 
(29,870
Other revenue
 
 
(36
 
 
281
 
 
 
7,871
 
 
 
1,048
 
 
 
9,164
 
Total revenue
 
 
518
 
 
 
(4,070
 
 
20,804
 
 
 
(105
 
 
17,147
 
Contract benefits and expenses
                                       
Net benefits and claims
 
 
 
 
 
(8,505
 
 
(1,572
 
 
778
 
 
 
(9,299
Commissions, investment and general expenses
 
 
42
 
 
 
3,099
 
 
 
13,798
 
 
 
(1,034
 
 
15,905
 
Other expenses
 
 
440
 
 
 
264
 
 
 
939
 
 
 
151
 
 
 
1,794
 
Total contract benefits and expenses
 
 
482
 
 
 
(5,142
 
 
13,165
 
 
 
(105
 
 
8,400
 
Income (loss) before income taxes
 
 
36
 
 
 
1,072
 
 
 
7,639
 
 
 
 
 
 
8,747
 
Income tax (expense) recovery
 
 
32
 
 
 
(23
 
 
(1,574
 
 
 
 
 
(1,565
Income (loss) after income taxes
 
 
68
 
 
 
1,049
 
 
 
6,065
 
 
 
 
 
 
7,182
 
Equity in net income (loss) of unconsolidated subsidiaries
 
 
7,226
 
 
 
997
 
 
 
2,046
 
 
 
(10,269
 
 
 
Net income (loss)
 
$
7,294
 
 
$
2,046
 
 
$
8,111
 
 
$
(10,269
)
 
 
$
7,182
 
Net income (loss) attributed to:
                                       
Non-controlling
interests
 
$
 
 
$
 
 
$
(1
 
$
 
 
$
(1
Participating policyholders
 
 
 
 
 
(236
 
 
125
 
 
 
 
 
 
(111
Shareholders and other equity holders
 
 
7,294
 
 
 
2,282
 
 
 
7,987
 
 
 
(10,269
 
 
7,294
 
 
 
$
  7,294
 
 
$
2,046
 
 
$
8,111
 
 
$
(10,269
)
 
$
7,182
 
Condensed Consolidated Statement of Income
 
For the year ended December 31, 2021   MFC
(Guarantor)
    JHUSA
(Issuer)
    Other
subsidiaries
    Consolidation
adjustments
    Consolidated
MFC
 
Revenue
                                       
Gross premiums
  $     $ 7,782     $ 37,563     $ (1,001   $ 44,344  
Premiums ceded to reinsurers
          (3,243     (3,031     995       (5,279
Net premium income
          4,539       34,532       (6     39,065  
Net investment income (loss)
    530       3,779       8,440       (1,125     11,624  
Other revenue
    33       2,042       9,605       (548     11,132  
Total revenue
    563       10,360       52,577       (1,679     61,821  
Contract benefits and expenses
                                       
Net benefits and claims
          6,478       28,467       877       35,822  
Commissions, investment and general expenses
    12       3,451       14,419       (1,436     16,446  
Other expenses
    390       212       1,946       (1,120     1,428  
Total contract benefits and expenses
    402       10,141       44,832       (1,679     53,696  
Income (loss) before income taxes
    161       219       7,745             8,125  
Income tax (expense) recovery
    (28     115       (1,300           (1,213
Income (loss) after income taxes
    133       334       6,445             6,912  
Equity in net income (loss) of unconsolidated subsidiaries
    6,972       1,218       1,552       (9,742      
Net income (loss)
  $ 7,105     $ 1,552     $ 7,997     $ (9,742   $ 6,912  
Net income (loss) attributed to:
                                       
Non-controlling
interests
  $    
$
    $ 255     $     $ 255  
Participating policyholders
          (4     (448     4       (448
Shareholders
    7,105       1,556       8,190       (9,746     7,105  
 
  $   7,105     $     1,552     $     7,997     $   (9,742   $     6,912  
 
Consolidated Statement of Cash Flows

 
For the year ended December 31, 2022
 
MFC
(Guarantor)
   
JHUSA
(Issuer)
   
Other
subsidiaries
   
Consolidation
adjustments
   
Consolidated
MFC
 
Operating activities
                                       
Net income (loss)
 
$
7,294
 
 
$
2,046
 
 
$
8,111
 
 
$
(10,269
 
$
7,182
 
Adjustments:
                                       
Equity in net income of unconsolidated subsidiaries
 
 
(7,226
 
 
(997
 
 
(2,046
 
 
10,269
 
 
 
 
Increase (decrease) in insurance contract liabilities
 
 
 
 
 
(20,032
 
 
(13,381
 
 
 
 
 
(33,413
Increase (decrease) in investment contract liabilities
 
 
 
 
 
44
 
 
 
(3
 
 
 
 
 
41
 
(Increase) decrease in reinsurance assets excluding coinsurance transactions
 
 
 
 
 
6,869
 
 
 
(6,710
 
 
 
 
 
159
 
Amortization of (premium) discount on invested assets
 
 
 
 
 
46
 
 
 
(78
 
 
 
 
 
(32
Other amortization
 
 
9
 
 
 
125
 
 
 
404
 
 
 
 
 
 
538
 
Net realized and unrealized (gains) losses and impairment on assets
 
 
(36
 
 
15,150
 
 
 
32,156
 
 
 
 
 
 
47,270
 
Gain on U.S. variable annuity reinsurance transaction
(pre-tax)
 
 
 
 
 
(1,026
 
 
(44
 
 
 
 
 
(1,070
Gain on derecognition of Joint Venture interest during Manulife TEDA acquisition (pre-tax)
 
 
 
 
 
 
 
 
(95
 
 
 
 
 
(95
Deferred income tax expense (recovery)
 
 
(33
 
 
294
 
 
 
470
 
 
 
 
 
 
731
 
Stock option expense
 
 
 
 
 
(3
 
 
8
 
 
 
 
 
 
5
 
Cash provided by (used in) operating activities before undernoted items
 
 
8
 
 
 
2,516
 
 
 
18,792
 
 
 
 
 
 
21,316
 
Dividends from unconsolidated subsidiary
 
 
6,200
 
 
 
399
 
 
 
734
 
 
 
(7,333
 
 
 
Cash decrease due to U.S. variable annuity reinsurance transaction
 
 
 
 
 
(1,263
 
 
(114
 
 
 
 
 
(1,377
Changes in policy related and operating receivables and payables
 
 
45
 
 
 
2,805
 
 
 
(5,054
)  
 
 
 
 
(2,204
Cash provided by (used in) operating activities
 
 
6,253
 
 
 
4,457
 
 
 
14,358
 
 
 
(7,333
 
 
17,735
 
Investing activities
                                       
Purchases and mortgage advances
 
 
 
 
 
(28,798
 
 
(82,970
 
 
 
 
 
(111,768)
 
Disposals and repayments
 
 
1
 
 
 
23,505
 
 
 
69,901
 
 
 
 
 
 
93,407
 
Changes in investment broker net receivables and payables
 
 
 
 
 
(11
 
 
(56
 
 
 
 
 
(67
Net cash increase (decrease) from sale (purchase) of subsidiary
 
 
 
 
 
 
 
 
(182
 
 
 
 
 
(182
Investment in common shares of subsidiaries
 
 
(2,479
 
 
 
 
 
 
 
 
2,479
 
 
 
 
Capital contribution to unconsolidated subsidiaries
 
 
 
 
 
(1
 
 
 
 
 
1
 
 
 
 
Return of capital from unconsolidated subsidiaries
 
 
 
 
 
19
 
 
 
 
 
 
(19
 
 
 
Notes receivable from parent
 
 
 
 
 
 
 
 
415
 
 
 
(415
 
 
 
Notes receivable from subsidiaries
 
 
46
 
 
 
(7
 
 
 
 
 
(39
 
 
 
Cash provided by (used in) investing activities
 
 
(2,432
 
 
(5,293
 
 
(12,892
 
 
2,007
 
 
 
(18,610
Financing activities
                                       
Issue of long-term debt, net
 
 
946
 
 
 
 
 
 
 
 
 
 
 
 
946
 
Redemption of capital instruments
 
 
 
 
 
 
 
 
(1,000
 
 
 
 
 
(1,000
Secured borrowings
 
 
 
 
 
 
 
 
437
 
 
 
 
 
 
437
 
Change in repurchase agreements and securities sold but not yet purchased
 
 
 
 
 
 
 
 
(551
 
 
 
 
 
(551
Changes in deposits from Bank clients, net
 
 
 
 
 
 
 
 
1,703
 
 
 
 
 
 
1,703
 
Lease payments
 
 
 
 
 
(5
 
 
(115
 
 
 
 
 
(120
Shareholders’ dividends and other equity distributions
 
 
(2,787
 
 
 
 
 
 
 
 
 
 
 
(2,787
Common shares repurchased
 
 
(1,884
 
 
 
 
 
 
 
 
 
 
 
(1,884
Common shares issued, net
 
 
23
 
 
 
 
 
 
2,479
 
 
 
(2,479
 
 
23
 
Preferred shares and other equity issued, net
 
 
990
 
 
 
 
 
 
 
 
 
 
 
 
990
 
Preferred shares redeemed, net
 
 
(711
 
 
 
 
 
 
 
 
 
 
 
(711
Contributions from (distributions to)
non-controlling
interests, net
 
 
 
 
 
 
 
 
(51
 
 
 
 
 
(51
Dividends paid to parent
 
 
 
 
 
(734
 
 
(6,599
 
 
7,333
 
 
 
 
Capital contributions by parent
 
 
 
 
 
 
 
 
1
 
 
 
(1
 
 
 
Return of capital to parent
 
 
 
 
 
 
 
 
(19
 
 
19
 
 
 
 
Notes payable to parent
 
 
 
 
 
 
 
 
(39
 
 
39
 
 
 
 
Notes payable to subsidiaries
 
 
(415
 
 
 
 
 
 
 
 
415
 
 
 
 
Cash provided by (used in) financing activities
 
 
(3,838
 
 
(739
 
 
(3,754
 
 
5,326
 
 
 
(3,005
Cash and short-term securities
                                       
Increase (decrease) during the year
 
 
(17
 
 
(1,575
 
 
(2,288
 
 
 
 
 
(3,880
Effect of foreign exchange rate changes on cash and short-term securities
 
 
2
 
 
 
225
 
 
 
358
 
 
 
 
 
 
585
 
Balance, beginning of year
 
 
78
 
 
 
3,565
 
 
 
18,287
 
 
 
 
 
 
21,930
 
Balance, end of year
 
 
63
 
 
 
2,215
 
 
 
16,357
 
 
 
 
 
 
18,635
 
Cash and short-term securities
                                       
Beginning of year
                                       
Gross cash and short-term securities
 
 
78
 
 
 
4,087
 
 
 
18,429
 
 
 
 
 
 
22,594
 
Net payments in transit, included in other liabilities
 
 
 
 
 
(522
 
 
(142
 
 
 
 
 
(664
Net cash and short-term securities, beginning of year
 
 
78
 
 
 
3,565
 
 
 
18,287
 
 
 
 
 
 
21,930
 
End of year
                                       
Gross cash and short-term securities
 
 
63
 
 
 
2,614
 
 
 
16,476
 
 
 
 
 
 
19,153
 
Net payments in transit, included in other liabilities
 
 
 
 
 
(399
 
 
(119
 
 
 
 
 
(518
Net cash and short-term securities, end of year
 
$
63
 
 
$
2,215
 
 
$
16,357
 
 
$
 
 
$
18,635
 
Supplemental disclosures on cash flow information:
                                       
Interest received
 
$
512
 
 
$
4,050
 
 
$
8,732
 
 
$
(1,161
 
$
12,133
 
Interest paid
 
 
424
 
 
 
118
 
 
 
1,867
 
 
 
(1,161
 
 
1,248
 
Income taxes paid
 
 
 
 
 
124
 
 
 
1,114
 
 
 
 
 
 
1,238
 
 
Consolidated Statement of Cash Flows
 
For the year ended December 31, 2021  
MFC
(Guarantor)
   
JHUSA
(Issuer)
   
Other
subsidiaries
   
Consolidation
adjustments
   
Consolidated
MFC
 
Operating activities
                                       
Net income (loss)
  $ 7,105     $ 1,552     $ 7,997     $   (9,742   $       6,912  
Adjustments:
                                       
Equity in net income of unconsolidated subsidiaries
    (6,972     (1,218     (1,552     9,742        
Increase (decrease) in insurance contract liabilities
          (562     11,281             10,719  
Increase (decrease) in investment contract liabilities
          50       (6           44  
(Increase) decrease in reinsurance assets excluding coinsurance transactions
          1,544       (790           754  
Amortization of (premium) discount on invested assets
          57       124             181  
Other amortization
    16       124       389             529  
Net realized and unrealized (gains) losses and impairment on assets
    62       1,533       3,229             4,824  
Deferred income tax expense (recovery)
    34       190       (351           (127
Stock option expense
          (2     11             9  
Cash provided by (used in) operating activities before undernoted items
    245       3,268       20,332             23,845  
Dividends from unconsolidated subsidiary
    5,000       489       742       (6,231      
Changes in policy related and operating receivables and payables
    (22     424       (1,092           (690
Cash provided by (used in) operating activities
    5,223       4,181       19,982       (6,231     23,155  
Investing activities
                                       
Purchases and mortgage advances
            (31,746       (89,219           (120,965
Disposals and repayments
          27,194       69,534             96,728  
Changes in investment broker net receivables and payables
          (202     16             (186
Investment in common shares of subsidiaries
    (3,700                 3,700        
Net cash flows from acquisition and disposal of subsidiaries and businesses
                (19           (19
Capital contribution to unconsolidated subsidiaries
          (1           1        
Return of capital from unconsolidated subsidiaries
          1             (1      
Notes receivable from parent
                (129     129        
Notes receivable from subsidiaries
    (13                 13        
Cash provided by (used in) investing activities
    (3,713     (4,754     (19,817     3,842       (24,442
Financing activities
                                       
Redemption of long-term debt
    (1,250                       (1,250
Redemption of capital instruments
    (468           (350           (818
Secured borrowings
                26             26  
Change in repurchase agreements and securities sold but not yet purchased
                186             186  
Changes in deposits from Bank clients, net
                (164           (164
Lease payments
          (7     (117           (124
Shareholders’ dividends and other equity distributions
    (2,500                       (2,500
Contributions from (distributions to)
non-controlling
interests, net
                (13           (13
Common shares issued, net
    51             3,700       (3,700     51  
Preferred shares and other equity issued, net
    3,171                         3,171  
Preferred shares redeemed, net
    (612                       (612
Dividends paid to parent
          (742     (5,489     6,231        
Capital contributions by parent
                1       (1      
Return of capital to parent
                (1     1        
Notes payable to parent
                13       (13      
Notes payable to subsidiaries
    129                   (129      
Cash provided by (used in) financing activities
      (1,479     (749     (2,208     2,389       (2,047
Cash and short-term securities
                                       
Increase (decrease) during the year
    31       (1,322     (2,043           (3,334
Effect of foreign exchange rate changes on cash and short-term securities
          (20     (299           (319
Balance, beginning of year
    47       4,907       20,629             25,583  
Balance, end of year
    78       3,565       18,287             21,930  
Cash and short-term securities
                                       
Beginning of year
                                       
Gross cash and short-term securities
    47       5,213       20,907             26,167  
Net payments in transit, included in other liabilities
          (306     (278           (584
Net cash and short-term securities, beginning of year
    47       4,907       20,629             25,583  
End of year
                                       
Gross cash and short-term securities
    78       4,087       18,429             22,594  
Net payments in transit, included in other liabilities
          (522     (142           (664
Net cash and short-term securities, end of year
  $ 78     $ 3,565     $ 18,287     $     $ 21,930  
Supplemental disclosures on cash flow information:
                                       
Interest received
  $ 499     $ 4,112     $ 7,847     $   (1,082   $ 11,376  
Interest paid
    396       73       1,594       (1,082     981  
Income taxes paid (refund)
          (118     689             571